Find an expert
Our panel of editors and experts are available for interview
Ian Mulvany
Chief Technology Officer, BMJ Group
Since joining BMJ Group in 2020 during the pandemic, Ian has led a sweeping digital transformation, strengthening the organisation’s infrastructure, accelerating its adoption of cloud-based platforms, and embedding AI and automation to improve delivery. Ian has a long track record of driving innovation in research technology. At SAGE Publishing, he founded SAGE Ocean, an incubator advancing new methods for social science research using big data. Earlier roles include Head of Technology at eLife Sciences, Head of Product at Mendeley, and Product Manager at Nature Publishing Group. He has also consistently advocated for open science, serving on the board of Dryad and the editorial board of the Journal of Open Research Software.
A recognised thought leader on digital transformation and AI in publishing, Ian has spoken at The London Book Fair, ALPSP, STM Week, and the International Association of Scientific, Technical and Medical Publishers (STM), as well as in podcasts and webinars on the future of open research, data, and AI adoption.
He regularly shares his reflections on technology, research, and innovation on his personal blog: mulvany.net
.
Mark G. Shrime, MD, MPH, PHD, FACS
Editor-in-Chief BMJ Global Health
Lecturer in Global Health and Social Medicine at the Harvard Medical School. I trained in otolaryngology, head and neck surgery, and microvascular reconstructive surgery. In 2011, I received a Masters in Public Health with a focus in global health, and in 2015, received my PhD in Health Policy with a focus on the science of decision making. In my academic life, I’ve authored seminal papers on the global burden of surgical disease, the financial burden facing surgical patients, and the number of people who cannot access safe surgery worldwide. I also had the privilege of serving as a co-author on the Lancet Commission on Global Surgery.
Professor Gisli Jenkins
Chair of the Editorial Board for BMJ Open Respiratory Research
Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London, Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium.
Professor Ronald F. van Vollenhoven
Editor-in-Chief of Lupus Science & Medicine
Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.
Professor Stephen Kaye
Editor-in-Chief BMJ Open Ophthalmology
Professor of Ophthalmology, Institute of Life Course and Medical Sciences, University of Liverpool where he leads the research into infections of the eye, Consultant Ophthalmologist Royal Liverpool University Hospital where he leads the Cornea and Ocular Surface Disease Service, Vice President of The Royal College of Ophthalmologists, Director of The Liverpool Research Eye Biobank, NHS England National lead for Corneal Transplantation, Honorary Professorship, Queens University, Belfast.
Dr James Mountford
Editor-in-Chief of BMJ Leader
Dr James Mountford is Director of Quality at Royal Free London NHS Foundation Trust. He worked initially as an NHS doctor, then in consulting. From 2005-2007, he was a Commonwealth Fund Health Foundation Harkness Fellow based in Massachusetts General Hospital, and at the Institute for Healthcare Improvement (IHI), both in Boston, USA. Before moving to the Royal Free, he was Director of Quality at UCL Partners, an academic health sciences partnership serving a population of 3 million in and around London. He sits on the board of AQuA, the improvement partnership based in north-west England. In March 2020 he was seconded to work as the Chief of Quality and Learning at the NHS Nightingale Hospital London, opened in response to the COVID-19 pandemic.
